Wall Street Zen Downgrades Rapid Micro Biosystems (NASDAQ:RPID) to Sell
by Amy Steele · The Cerbat GemRapid Micro Biosystems (NASDAQ:RPID – Get Free Report) was downgraded by investment analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Sunday.
Separately, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Rapid Micro Biosystems in a research note on Wednesday, October 8th. One equities research analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $8.00.
View Our Latest Research Report on Rapid Micro Biosystems
Rapid Micro Biosystems Price Performance
Shares of NASDAQ:RPID opened at $2.90 on Friday. The firm has a 50 day moving average of $3.52 and a 200-day moving average of $3.33. The stock has a market capitalization of $128.53 million, a PE ratio of -2.87 and a beta of 1.33. The company has a current ratio of 4.23, a quick ratio of 2.95 and a debt-to-equity ratio of 0.42. Rapid Micro Biosystems has a 12 month low of $0.87 and a 12 month high of $4.50.
Rapid Micro Biosystems (NASDAQ:RPID – Get Free Report) last posted its quarterly earnings results on Friday, November 7th. The company reported ($0.26) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.26). Rapid Micro Biosystems had a negative net margin of 145.11% and a negative return on equity of 73.90%. The business had revenue of $7.84 million for the quarter, compared to analyst estimates of $7.60 million. On average, equities research analysts predict that Rapid Micro Biosystems will post -1.1 EPS for the current fiscal year.
Institutional Trading of Rapid Micro Biosystems
Hedge funds have recently made changes to their positions in the company. Geode Capital Management LLC increased its stake in shares of Rapid Micro Biosystems by 1.6% in the second quarter. Geode Capital Management LLC now owns 204,079 shares of the company’s stock valued at $704,000 after buying an additional 3,143 shares during the period. American Century Companies Inc. grew its holdings in Rapid Micro Biosystems by 46.1% during the 2nd quarter. American Century Companies Inc. now owns 16,922 shares of the company’s stock worth $58,000 after acquiring an additional 5,341 shares during the last quarter. Susquehanna International Group LLP increased its position in Rapid Micro Biosystems by 12.6% in the 3rd quarter. Susquehanna International Group LLP now owns 58,387 shares of the company’s stock valued at $195,000 after acquiring an additional 6,528 shares during the period. Hudson Bay Capital Management LP bought a new position in shares of Rapid Micro Biosystems during the third quarter valued at $38,000. Finally, Dimensional Fund Advisors LP raised its stake in shares of Rapid Micro Biosystems by 37.8% during the third quarter. Dimensional Fund Advisors LP now owns 55,642 shares of the company’s stock valued at $186,000 after acquiring an additional 15,255 shares during the last quarter. 52.60% of the stock is owned by institutional investors and hedge funds.
About Rapid Micro Biosystems
Rapid Micro Biosystems (NASDAQ: RPID) develops and commercializes automated microbial detection and contamination control solutions for the life sciences industry. Its flagship offering, the Growth Direct® System, leverages digital imaging and proprietary growth indicator plates to identify and count microorganisms more rapidly than traditional culture-based methods. The company’s technology platform is designed to streamline quality control workflows in pharmaceutical, biotechnology and vaccine manufacturing settings, helping clients reduce release times and improve operational efficiency.
In addition to the Growth Direct® System, Rapid Micro Biosystems offers an integrated suite of software and consumables that support automated data capture, analysis and reporting.